INSPECS Group (SPEC) Share Price, News & Analysis

Company Overview

Inspecs is a designer, manufacturer and distributor of eyewear frames. The Group produces a broad range of frames, covering optical, sunglasses and safety, which are either “Branded” (either under licence or under the Group’s own proprietary brands), or “OEM” (including private label on behalf of retail customers and un-branded). As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well positioned to continue to take market share in the globally expanding eyewear market. Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 30,000 points of sale. In FY19, the Group generated 24.9 per cent. of its revenue in the UK and 75.1 per cent. internationally. Today Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, London and more recently, Italy. The Group’s growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group’s internal capabilities); and (iii) extend the Group’s manufacturing capacity. More information is available at: https://inspecs.com

Key Stats

• Today's Range: 45.60 to 47.50
• 50-Day Range: 38.26 to 52
• 52-Week Range: 38 to 78
• Volume: 251,629 shs
• Average Volume: 286,135 shs
• Market Capitalization: £48.29 million
• P/E Ratio: N/A
• Dividend Yield: 2.11%
• Price Target: N/A
• Consensus Rating: N/A

SPEC Stock Analysis - Frequently Asked Questions

How have SPEC shares performed this year?

INSPECS Group's stock was trading at GBX 45.10 on January 1st, 2025. Since then, SPEC shares have increased by 5.3% and is now trading at GBX 47.50.
View the best growth stocks for 2025 here.

How do I buy shares of INSPECS Group?

Shares of SPEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of INSPECS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that INSPECS Group investors own include ConvaTec Group (CTEC), Guild Esports (GILD), Trifast (TRI), Allied Gaming & Entertainment (AGAE), C3.ai (AI), Avino Silver & Gold Mines (ASM) and Avino Silver & Gold Mines (ASM).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: LON:SPEC
• CUSIP: N/A
• CIK: N/A
• Web: inspecs.com
• Phone: 44 1125 717 000
• Fax: N/A
• Employees: 1,673
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (4.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 8.56
• P/E Growth: N/A
• Net Income: £-4,106,999.00
• Net Margins: -2.10%
• Pretax Margin: N/A
• Return on Equity: -4.00%
• Return on Assets: 0.45%

Debt

• Debt-to-Equity Ratio: 43.59
• Current Ratio: 1.46
• Quick Ratio: 0.89

Sales & Book Value

• Annual Sales: £195.14 million
• Price / Sales: 0.25
• Cash Flow: GBX 29.18 per share
• Price / Cash Flow: 1.63
• Book Value: GBX 100.26 per share
• Price / Book: 0.47

Miscellaneous

• Outstanding Shares: 101,672,000
• Free Float: N/A
• Market Cap: £48.29 million
• Optionable: Not Optionable
• Beta: 2.22